EG24065A - Monohydrate of cis-lithium-4-cyano-4-(3-cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylate - Google Patents
Monohydrate of cis-lithium-4-cyano-4-(3-cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylateInfo
- Publication number
- EG24065A EG24065A EG20010070A EG20010070A EG24065A EG 24065 A EG24065 A EG 24065A EG 20010070 A EG20010070 A EG 20010070A EG 20010070 A EG20010070 A EG 20010070A EG 24065 A EG24065 A EG 24065A
- Authority
- EG
- Egypt
- Prior art keywords
- cyclohexanecarboxylate
- cyclopentyloxy
- monohydrate
- methoxyphenyl
- cis
- Prior art date
Links
- NZNMSOFKMUBTKW-UHFFFAOYSA-M cyclohexanecarboxylate Chemical compound [O-]C(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-M 0.000 title 1
- 150000004682 monohydrates Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17812900P | 2000-01-26 | 2000-01-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG24065A true EG24065A (en) | 2008-05-08 |
Family
ID=22651319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG20010070A EG24065A (en) | 2000-01-26 | 2001-01-24 | Monohydrate of cis-lithium-4-cyano-4-(3-cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylate |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US6699903B2 (fr) |
| EP (1) | EP1250313B1 (fr) |
| JP (1) | JP2003520842A (fr) |
| KR (1) | KR20020073183A (fr) |
| CN (1) | CN1157371C (fr) |
| AP (1) | AP1432A (fr) |
| AR (1) | AR027273A1 (fr) |
| AT (1) | ATE344235T1 (fr) |
| AU (1) | AU3282201A (fr) |
| BG (1) | BG106959A (fr) |
| BR (1) | BR0107709A (fr) |
| CA (1) | CA2397758A1 (fr) |
| CO (1) | CO5300517A1 (fr) |
| CY (1) | CY1108515T1 (fr) |
| CZ (1) | CZ20022590A3 (fr) |
| DE (1) | DE60124221T2 (fr) |
| DK (1) | DK1250313T3 (fr) |
| DZ (1) | DZ3285A1 (fr) |
| EA (1) | EA200200791A1 (fr) |
| EG (1) | EG24065A (fr) |
| ES (1) | ES2273804T3 (fr) |
| HK (1) | HK1051030A1 (fr) |
| HU (1) | HUP0204150A3 (fr) |
| IL (1) | IL150400A0 (fr) |
| MA (1) | MA25652A1 (fr) |
| MX (1) | MXPA02007300A (fr) |
| MY (1) | MY122802A (fr) |
| NO (1) | NO20023378L (fr) |
| NZ (1) | NZ519799A (fr) |
| OA (1) | OA12159A (fr) |
| PE (1) | PE20011040A1 (fr) |
| PL (1) | PL356832A1 (fr) |
| PT (1) | PT1250313E (fr) |
| SK (1) | SK10942002A3 (fr) |
| WO (1) | WO2001055094A1 (fr) |
| ZA (1) | ZA200205925B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0011802D0 (en) * | 2000-05-16 | 2000-07-05 | Smithkline Beecham | Method for enhancing cognitive function |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2133439C (fr) * | 1992-04-02 | 2005-07-26 | Siegfried Benjamin Christensen, Iv | Composes utiles pour le traitement des maladies d'origine allergique et inflammatoire |
| UA67753C2 (uk) * | 1997-10-10 | 2004-07-15 | Смітклайн Бічам Корпорейшн | Спосіб отримання заміщених 4-феніл-4-ціанциклогексанових кислот |
-
2001
- 2001-01-18 HK HK03101828.3A patent/HK1051030A1/zh unknown
- 2001-01-18 AP APAP/P/2002/002566A patent/AP1432A/en active
- 2001-01-18 ES ES01904886T patent/ES2273804T3/es not_active Expired - Lifetime
- 2001-01-18 MX MXPA02007300A patent/MXPA02007300A/es active IP Right Grant
- 2001-01-18 NZ NZ519799A patent/NZ519799A/en unknown
- 2001-01-18 EP EP01904886A patent/EP1250313B1/fr not_active Expired - Lifetime
- 2001-01-18 PT PT01904886T patent/PT1250313E/pt unknown
- 2001-01-18 EA EA200200791A patent/EA200200791A1/ru unknown
- 2001-01-18 KR KR1020027009545A patent/KR20020073183A/ko not_active Ceased
- 2001-01-18 CN CNB018040160A patent/CN1157371C/zh not_active Expired - Fee Related
- 2001-01-18 CZ CZ20022590A patent/CZ20022590A3/cs unknown
- 2001-01-18 US US10/181,865 patent/US6699903B2/en not_active Expired - Fee Related
- 2001-01-18 DZ DZ013285A patent/DZ3285A1/fr active
- 2001-01-18 SK SK1094-2002A patent/SK10942002A3/sk unknown
- 2001-01-18 BR BR0107709-0A patent/BR0107709A/pt not_active IP Right Cessation
- 2001-01-18 DE DE60124221T patent/DE60124221T2/de not_active Expired - Lifetime
- 2001-01-18 OA OA1200200211A patent/OA12159A/en unknown
- 2001-01-18 DK DK01904886T patent/DK1250313T3/da active
- 2001-01-18 AU AU32822/01A patent/AU3282201A/en not_active Abandoned
- 2001-01-18 IL IL15040001A patent/IL150400A0/xx unknown
- 2001-01-18 WO PCT/US2001/001487 patent/WO2001055094A1/fr not_active Ceased
- 2001-01-18 PL PL01356832A patent/PL356832A1/xx not_active IP Right Cessation
- 2001-01-18 CA CA002397758A patent/CA2397758A1/fr not_active Abandoned
- 2001-01-18 HU HU0204150A patent/HUP0204150A3/hu unknown
- 2001-01-18 JP JP2001555036A patent/JP2003520842A/ja not_active Withdrawn
- 2001-01-18 AT AT01904886T patent/ATE344235T1/de not_active IP Right Cessation
- 2001-01-23 MY MYPI20010322A patent/MY122802A/en unknown
- 2001-01-24 AR ARP010100298A patent/AR027273A1/es unknown
- 2001-01-24 EG EG20010070A patent/EG24065A/xx active
- 2001-01-25 PE PE2001000081A patent/PE20011040A1/es not_active Application Discontinuation
- 2001-01-26 CO CO01005892A patent/CO5300517A1/es not_active Application Discontinuation
-
2002
- 2002-07-12 NO NO20023378A patent/NO20023378L/no not_active Application Discontinuation
- 2002-07-24 MA MA26744A patent/MA25652A1/fr unknown
- 2002-07-24 ZA ZA200205925A patent/ZA200205925B/en unknown
- 2002-07-26 BG BG106959A patent/BG106959A/xx unknown
-
2007
- 2007-01-10 CY CY20071100034T patent/CY1108515T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002364517A1 (en) | Tramadol analogs and uses thereof | |
| AU2002358718A1 (en) | 2-heteroarylcarboxylic acid amides | |
| AU3494801A (en) | Surgical fastener | |
| EG24138A (en) | Asymmetrics synthesis of pregabalin | |
| AU2002250331A1 (en) | 7-pyrollyl tetracycline compounds and methods of use thereof | |
| LT1366018T (lt) | (r)-2-arilpropiono rūgščių omega-amino alkilamidai kaip polimorfonuklearinių ir mononuklearinių ląstelių chemotaksio inhibitoriai | |
| PL350193A1 (en) | Sulfamato hydroxamic acid metalloprotease inhibitor | |
| HUP0302847A3 (en) | Pharmaceutical formulation comprising bicalutamide | |
| HUP0302478A3 (en) | Pharmaceutical solutions of modafinil compounds | |
| IL161902A0 (en) | Pharmaceutical formulation comprising bicalutamide | |
| AU2001261211A1 (en) | Anhydrous skin cleansers | |
| PL363741A1 (en) | Novel n-p-propargyloxyphenethyl-thioacetic acid amides | |
| EG24065A (en) | Monohydrate of cis-lithium-4-cyano-4-(3-cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylate | |
| AU2002246926A1 (en) | 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof | |
| SG119168A1 (en) | Utilization of at least one aminopeptidase inhibitor | |
| HUP0401782A3 (en) | New anhydrous crystalline forms of gabapentin | |
| AU2002358719A1 (en) | Agaricoglycerides and analogs | |
| SI1250313T1 (sl) | Monohidrat cis-litij-ciano-4(3-(ciklopentiloksi)-4-metoksifenil) cikloheksankarboksilata | |
| AU2002210989A1 (en) | Cyclopropanecarboxylic acid amide compounds and medicinal use thereof | |
| AU2001260200A1 (en) | Novel alpha-sulfin- and alpha-sulfonamino acid amides | |
| GB0124554D0 (en) | Debugging of processors | |
| GB0124555D0 (en) | Debugging of processors | |
| AU2002334120A1 (en) | Debugging of processors | |
| AU2002329478A1 (en) | Debugging of processors | |
| AU2002316827A1 (en) | Novel n-p-propargyloxyphenethyl-thioacetic acid amides |